60
Views
2
CrossRef citations to date
0
Altmetric
Review

Pharmacogenetics and nutritional supplementation in age-related macular degeneration

, &
Pages 873-876 | Published online: 15 May 2015

References

  • ResnikoffSPascoliniDEtya’aleDGlobal data on visual impairment in the year 2002Bull World Health Organ2004821184485115640920
  • FriedmanDSO’ColmainBJMunozBPrevalence of age-related macular degeneration in the United StatesArch Ophthalmol2004122456457215078675
  • Age-Related Eye Disease Study Research GroupA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol2001119101417143611594942
  • Age-Related Eye Disease Study 2 Research GroupLutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trialJAMA2013309192005201523644932
  • OmennGSGoodmanGEThornquistMDEffects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular diseaseN Engl J Med199633418115011558602180
  • SchwartzSGBrantleyMAJrPharmacogenetics and age-related macular degenerationJ Ophthalmol2011201125249
  • HagstromSAYingGSPauerGJPharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)Ophthalmology2013120359359923337555
  • LoteryAJGibsonJCreeAJPharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN studyOphthalmology2013120122637264324070809
  • KleinMLFrancisPJRosnerBCFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degenerationOphthalmology200811561019102518423869
  • AwhCCLaneAMHawkenSZankeBKimIKCFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degenerationOphthalmology2013120112317232323972322
  • ChewEYKleinMLClemonsTENo Clinically Significant Association between CFH and ARMS2 Genotypes and Response to Nutritional Supplements: AREDS Report Number 38Ophthalmology2014121112173218024974817
  • AwhCCHawkenSZankeBWTreatment Response to Antioxidants and Zinc Based on CFH and ARMS2 Genetic Risk Allele Number in the Age-Related Eye Disease StudyOphthalmology2015122116216925200399
  • ChewEYKleinMLClemonsTEAgronEAbecasisGRGenetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?Ophthalmology2015122121221525456150
  • StoneEMGenetic testing for age-related macular degeneration: not indicated nowJAMA Ophthalmol Epub2015319
  • GrobSLuoJHughesGGenetic analysis of simultaneous geographic atrophy and choroidal neovascularizationEye (Lond)20122681106111322699975
  • SchwartzSGRe: Awh et al.: CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration (Ophthalmology 2013;120:2317–23)Ophthalmology20141218e3824793508
  • WittesJMuschDCShould we test for genotype in deciding on Age-Related Eye Disease Study supplementation?Ophthalmology201512213525542537
  • StoneEMAldaveAJDrackAVRecommendations for genetic testing of inherited eye diseases: report of the American Academy of Ophthalmology task force on genetic testingOphthalmology2012119112408241022944025